Aurobindo’s Acrotech Biopharma to acquire oncology products from Spectrum Pharmaceuticals
EAST WINDSOR, N.J. — Aurobindo Pharma announces the signing of a definitive agreement to acquire a portfolio of seven branded oncology injectable products from Spectrum Pharmaceuticals Inc. The acquisition also brings-in an experienced branded commercial infrastructure in the U.S. Acrotech Biopharma, a wholly-owned subsidiary of Aurobindo Pharma USA Inc., which in turn a wholly-owned subsidiary of Aurobindo Pharma
